This is a randomized, double blind, placebo control, multi-centre clinical study in hyperlipidemia patients.~Enrolled subjects will be randomized to the treatment group or control group, and receive Probucol or placebo continuously for 8 weeks; Treatment group: Imported Probucol 250 mg (1 tablet) bid. p.o Control group: Placebo 1 tablet bid. p.o
The purpose of this study is to evaluate the efficacy and safety of imported Probucol in hyperlipidemia patients.